SCHEMBL1799415

SCHEMBL1799415

O=C(COCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 1/20 0.55
▸ RHOC P08134 3/20 0.55
▸ RHOA P61586 3/20 0.55
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ GAA P10253 2/20 0.52
▸ MAPT P10636 1/20 0.52
▸ XBP1 P17861 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ P2RX1 P51575 4/20 0.52
▸ P2RX4 Q99571 3/20 0.52
▸ P2RX7 Q99572 3/20 0.52
▸ TMPRSS4 Q9NRS4 3/20 0.52
▸ IKBKB O14920 1/20 0.52
▸ CHUK O15111 1/20 0.52
▸ KDR P35968 1/20 0.52
▸ FLT3 P36888 1/20 0.52
▸ MYLK Q15746 1/20 0.52
▸ MAP4K5 Q9Y4K4 1/20 0.52
▸ SERPINE1 P05121 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1799371 0.89 RHOC (0.53) MPORHOCRHOAMEN1KMT2A
SCHEMBL1797569 0.84 SERPINE1 (0.56) MEN1KMT2AGAAMAPTSERPINE1
SCHEMBL1795944 0.80 SERPINE1 (0.45) MPOMEN1KMT2AGAASERPINE1
SCHEMBL1015269 0.80 GRIK1 (0.52) MEN1KMT2AGAAMAPTP2RX1
SCHEMBL1015135 0.79 GRIK1 (0.51) MEN1KMT2AGAAMAPTP2RX1
SCHEMBL418647 0.77 SERPINE1 (0.66) MPOSERPINE1KDM4EHSD17B10PPARG
SCHEMBL1015619 0.76 SERPINE1 (0.49) GAAMAPTSERPINE1POLBG6PD
SCHEMBL1796212 0.76 TP53 (0.69) MEN1KMT2AGAAMAPTSERPINE1
SCHEMBL1015276 0.76 SERPINE1 (0.65) GAASERPINE1POLBG6PDKDM4E
SCHEMBL1012592 0.75 SERPINE1 (0.64) GAASERPINE1POLBG6PDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US claimed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US claimed
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 — — US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 — — US disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 — — EP disclosed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 MPO 534/4885RHOC 4404/4885RHOA 3874/4885
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 MPO 183/4885RHOC 3393/4885RHOA 751/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 MPO 407/4885RHOC 4442/4885RHOA 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback